Barings Real Estate Advisers’s PHYSICIANS REALTY TRUST DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9.67M Buy
510,090
+168,829
+49% +$3.2M 3.29% 12
2016
Q3
$7.35M Buy
341,261
+44,653
+15% +$944K 2.3% 20
2016
Q2
$6.23M Buy
296,608
+102,305
+53% +$1.96M 2.06% 25
2016
Q1
$3.61M Buy
194,303
+31,783
+20% +$548K 1.76% 24
2015
Q4
$2.74M Buy
162,520
+9,080
+6% +$145K 1.34% 28
2015
Q3
$2.31M Sell
153,440
-42,087
-22% -$647K 1.27% 25
2015
Q2
$3M Buy
195,527
+32,490
+20% +$538K 1.35% 23
2015
Q1
$2.87M Buy
163,037
+91,296
+127% +$1.54M 1.37% 24
2014
Q4
$1.19M Sell
71,741
-500
-0.7% -$7.63K 0.59% 37
2014
Q3
$991K Buy
72,241
+5,630
+8% +$80.5K 0.75% 39
2014
Q2
$959K Buy
66,611
+14,202
+27% +$194K 0.7% 41
2014
Q1
$730K Buy
52,409
+1,850
+4% +$24K 0.56% 44
2013
Q4
$644K Buy
50,559
+25,239
+100% +$312K 0.46% 42
2013
Q3
$307K Buy
+25,320
New +$296K 0.19% 46

Other funds holding DOC

Barings Real Estate Advisers's DOC Position: Q4 2016 in Review

Barings Real Estate Advisers increased its PHYSICIANS REALTY TRUST (DOC) stake by 49% in Q4 2016, buying an estimated $3.2M and bringing the position to 510,090 shares worth $9.67M. The position accounts for 3.29% of the portfolio, ranked #12.

Barings Real Estate Advisers first reported a position in DOC in Q3 2013 and has held it in 14 quarters since. 220 funds tracked by Wall St. Rank hold DOC as of Q4 2016.

  • Barings Real Estate Advisers held 510,090 shares of PHYSICIANS REALTY TRUST worth $9.67M as of Q4 2016.
  • Barings Real Estate Advisers bought 168,829 PHYSICIANS REALTY TRUST shares in Q4 2016, an estimated $3.2M.
  • PHYSICIANS REALTY TRUST made up 3.29% of Barings Real Estate Advisers's portfolio in Q4 2016, its #12 holding.
  • Barings Real Estate Advisers first reported a position in PHYSICIANS REALTY TRUST in Q3 2013 and has held it in 14 quarters since.
  • 220 funds tracked by Wall St. Rank held PHYSICIANS REALTY TRUST as of Q4 2016.

Based on Barings Real Estate Advisers's 13F filing for Q4 2016, filed 1 Feb 2017.